trending Market Intelligence /marketintelligence/en/news-insights/trending/g2-pgzxkxk2ribe5xwgopq2 content esgSubNav
In This List

Astellas appoints CEO/president

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Astellas appoints CEO/president

Japan's Astellas Pharma Inc. appointed Kenji Yasukawa CEO and president, effective April 1.

Yasukawa is executive vice president of the pharmaceutical company. He will remain a representative director following the transition.

Further, Yoshihiko Hatanaka, Astellas' current CEO and president, will serve as chairman of the board starting April 1. He will also remain a representative director following the transition.